Rapid Communication
Copyright ©2008 The WJG Press and Baishideng.
World J Gastroenterol. Sep 21, 2008; 14(35): 5461-5466
Published online Sep 21, 2008. doi: 10.3748/wjg.14.5461
Figure 4
Figure 4 A: Effect of a membrane-permeable PKG-specific inhibitor, KT-5823, on STOCs (n = 10); B: Effect of KT-5720 (500 nmol/L), a PKA-specific inhibitor, on STOCs (n = 10).